GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Cyclically Adjusted Price-to-FCF

Amicogen (XKRX:092040) Cyclically Adjusted Price-to-FCF : (As of May. 13, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Amicogen Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Amicogen Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Amicogen's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicogen Cyclically Adjusted Price-to-FCF Chart

Amicogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Amicogen Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Amicogen's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Amicogen's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amicogen's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amicogen's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Amicogen's Cyclically Adjusted Price-to-FCF falls into.



Amicogen Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Amicogen's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Amicogen's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-504.801/118.8477*118.8477
=-504.801

Current CPI (Dec. 2023) = 118.8477.

Amicogen Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -9.720 99.253 -11.639
201406 1.131 99.353 1.353
201409 26.934 99.608 32.136
201412 -33.738 99.098 -40.462
201503 -46.302 99.720 -55.183
201506 57.532 100.050 68.341
201509 34.784 100.110 41.295
201512 80.879 100.220 95.912
201603 -1.986 100.560 -2.347
201606 -64.961 100.790 -76.600
201609 -78.118 101.460 -91.505
201612 3.441 101.560 4.027
201703 -58.325 102.850 -67.397
201706 -13.745 102.610 -15.920
201709 0.903 103.490 1.037
201712 58.063 102.990 67.003
201803 -0.910 104.100 -1.039
201806 -183.645 104.130 -209.601
201809 -91.230 105.650 -102.626
201812 43.410 104.350 49.441
201903 122.447 104.490 139.272
201906 -308.206 104.880 -349.252
201909 -3.086 105.200 -3.486
201912 -216.263 105.120 -244.505
202003 -150.559 105.540 -169.543
202006 -90.817 104.870 -102.922
202009 9.383 106.200 10.500
202012 54.596 105.765 61.349
202103 -55.667 107.357 -61.625
202106 -336.960 107.579 -372.257
202109 -619.691 108.759 -677.174
202112 -139.753 109.676 -151.439
202203 -447.238 111.806 -475.407
202206 -563.697 114.083 -587.241
202209 -416.375 114.831 -430.938
202212 -198.539 115.200 -204.825
202303 -100.534 116.550 -102.516
202306 -305.540 117.140 -309.995
202309 -488.138 119.111 -487.058
202312 -504.801 118.848 -504.801

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Amicogen  (XKRX:092040) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Amicogen Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Amicogen's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Amicogen (XKRX:092040) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1259-64, Dongbu-ro, Gyeongsangnam-do, Jinseong-myeon, KOR, 660-852
Amicogen, Inc. is an industrial biotechnology company operating in Korea. It is engaged in development, production and distribution of enzymes, bio new materials and healthcare food. The company's products portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins.

Amicogen (XKRX:092040) Headlines

No Headlines